Cure Genetics
Cure Genetics (克睿基因) is a clinical-stage biotechnology company founded in 2016 and based in Suzhou, Jiangsu, China, developing cell and gene therapies for solid tumors and genetic diseases. Its differentiated pipeline is built on two proprietary platforms: AIMS CAR-NKT, a cell-therapy approach engineered to improve solid-tumor infiltration and modulate the tumor microenvironment, and VELP, an AAV (adeno-associated viral) vector technology targeting the nervous system, heart, and kidneys. Lead programs include CGC729, an anti-CD70 CAR-NKT therapy in Phase I trials for renal cell carcinoma, and CGC-602, a PD-1-IL-2v bispecific molecule for cancer immunotherapy. The company is backed by Qiming Venture Partners, Advantech Capital, and Oriza Holdings. It publishes no public API, developer platform, or technical documentation; this profile is maintained in the API Evangelist network as a company record surfaced from the Qiming portfolio.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Cure Genetics the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Cure Genetics scores 8.8/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Cure Genetics
Each block below is one kind of artifact we hold for Cure Genetics. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Cure Genetics — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 2
The organization behind the API
← All providers · Data indexed from github.com/api-evangelist/curegenetics · machine-readable index on apis.io